Literature DB >> 15967114

[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.

Marcelo Mamede1, Tatsuya Higashi, Masanori Kitaichi, Koichi Ishizu, Takayoshi Ishimori, Yuji Nakamoto, Kazuhiro Yanagihara, Mio Li, Fumihiro Tanaka, Hiromi Wada, Toshiaki Manabe, Tsuneo Saga.   

Abstract

PURPOSE: The aim of this study was to evaluate the relationships among [18F]fluorodeoxyglucose ([18F]-FDG) uptake, Glut-1 and HK-II expressions, and grade of inflammation in resected lung lesions.
MATERIALS AND METHODS: Sixty patients had undergone preoperative 18F-FDG-PET imaging and thoracotomy. For semiquantitative analysis of 18F-FDG uptake, partial volume effect corrected maximum standardized uptake values (pSUVs) were calculated. Immunohistochemical staining was performed in resected specimens using anti-Glut-1, anti-HK-II, and anti-proliferative cellular nuclear antigen (PCNA) antibodies, and immunoreactivities were scored as G-, H-, and P-indexes on a five-point scale (0: 0%; 1: 20%, 2: 40%; 3: 60%; 4: 80%, and 5: 100% percentages of strongly immunoreactive cells).Grade of inflammation was also evaluated.
RESULTS: The malignant lesions had higher pSUV and higher G- and H- than nonmalignant lesions. pSUVs correlated with the G- (p < .001), H- (p < .01), and P-indexes (p < .01) in malignant lesions. In adenocarcinomas, cancers with lower differentiation showed higher expression of Glut-1 and HK-II than those with higher differentiation. A positive linear regression was observed between pSUVs and the grading of inflammation in nonmalignant lesions (p < .05).
CONCLUSIONS: Our study indicates that 18F-FDG uptake in lung cancer correlates well with the Glut-1, HK-II, and PCNA expression. For nonmalignant lesions, the presence of a higher inflammatory process correlated with 18F-FDG uptake.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967114      PMCID: PMC1501150          DOI: 10.1593/neo.04577

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  44 in total

Review 1.  Application of metabolic-control logic to fuel utilization and its significance in tumor cells.

Authors:  E A Newsholme; M Board
Journal:  Adv Enzyme Regul       Date:  1991

2.  Deoxyglucose kinetics in a rat brain tumor.

Authors:  M M Graham; A M Spence; M Muzi; G L Abbott
Journal:  J Cereb Blood Flow Metab       Date:  1989-06       Impact factor: 6.200

Review 3.  Enzymology of cancer cells (first of two parts).

Authors:  G Weber
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

4.  FDG accumulation in tumor tissue.

Authors:  K Kubota; R Kubota; S Yamada
Journal:  J Nucl Med       Date:  1993-03       Impact factor: 10.057

5.  Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription.

Authors:  M J Birnbaum; H C Haspel; O M Rosen
Journal:  Science       Date:  1987-03-20       Impact factor: 47.728

6.  Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat.

Authors:  R Paul; R Johansson; P L Kellokumpu-Lehtinen; K O Söderström; L Kangas
Journal:  Res Exp Med (Berl)       Date:  1985

7.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

Authors:  E F Patz; V J Lowe; J M Hoffman; S S Paine; P Burrowes; R E Coleman; P C Goodman
Journal:  Radiology       Date:  1993-08       Impact factor: 11.105

8.  Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location.

Authors:  D M Parry; P L Pedersen
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

9.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Authors:  K Hamacher; H H Coenen; G Stöcklin
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

10.  Characterisation of macrophages infiltrating human mammary carcinomas.

Authors:  R J Steele; M Brown; O Eremin
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

View more
  73 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Human Immunodeficiency Virus-Associated Immune Reconstitution Inflammatory Syndrome.

Authors:  Dima A Hammoud; Afroditi Boulougoura; Georgios Z Papadakis; Jing Wang; Lori E Dodd; Adam Rupert; Jeanette Higgins; Gregg Roby; Dorinda Metzger; Elizabeth Laidlaw; JoAnn M Mican; Alice Pau; Silvia Lage; Chun-Shu Wong; Andrea Lisco; Maura Manion; Virginia Sheikh; Corina Millo; Irini Sereti
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

3.  FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future.

Authors:  Abdullah Al-Zaghal; William Y Raynor; Siavash Mehdizadeh Seraj; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01       Impact factor: 9.236

Review 4.  Imaging subclinical atherosclerosis: is it ready for prime time? A review.

Authors:  Leticia Fernández-Friera; Borja Ibáñez; Valentín Fuster
Journal:  J Cardiovasc Transl Res       Date:  2014-08-14       Impact factor: 4.132

Review 5.  Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.

Authors:  Y Waerzeggers; R T Ullrich; P Monfared; T Viel; M Weckesser; W Stummer; O Schober; A Winkeler; A H Jacobs
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

6.  Use of PET/CT scanning in cancer patients: technical and practical considerations.

Authors:  Landis K Griffeth
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

7.  Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis.

Authors:  Irem H Ozbudak; Konstantin Shilo; Fabio Tavora; Negar Rassaei; Wei-Sing Chu; Junya Fukuoka; Jin Jen; William D Travis; Teri J Franks
Journal:  Mod Pathol       Date:  2009-02-20       Impact factor: 7.842

Review 8.  18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Authors:  Hossein Jadvar; Abass Alavi; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

9.  A false positive F-FDG PET/CT scan caused by breast silicone injection.

Authors:  Chao-Jung Chen; Bi-Fang Lee; Wei-Jen Yao; Pei-Shan Wu; Wen-Chung Chen; Shu-Lin Peng; Nan-Tsing Chiu
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

10.  (18)F-FDG PET analysis of schwannoma: increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors.

Authors:  Kenichiro Hamada; Yasuhiko Tomita; Ying Qiu; Miki Tomoeda; Takafumi Ueda; Noriyuki Tamai; Nobuyuki Hashimoto; Hideki Yoshikawa; Katsuyuki Aozasa; Jun Hatazawa
Journal:  Skeletal Radiol       Date:  2008-12-17       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.